Literature DB >> 7883908

Severe osteomyelitis due to the zygomycete Apophysomyces elegans.

J F Meis1, B J Kullberg, M Pruszczynski, R P Veth.   

Abstract

We describe a previously healthy 69-year-old man presenting with osteomyelitis of the humerus due to the zygomycete Apophysomyces elegans. The infection was acquired in Aruba, The Netherlands Antilles. The skin provided the most likely portal of entry, although there was no history of a traumatic inoculation. The patient had no history of diabetes, and no underlying immune defects were found. Despite treatment with 7.9 g of amphotericin B, an interthoracoscapular amputation proved necessary to curtail the rapid spread of the fungus in this immunocompetent host.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7883908      PMCID: PMC264235          DOI: 10.1128/jcm.32.12.3078-3081.1994

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  16 in total

Review 1.  Opportunistic mycotic osteomyelitis: bone infections due to Aspergillus and Candida species.

Authors:  M B Simpson; W G Merz; J P Kurlinski; M H Solomon
Journal:  Medicine (Baltimore)       Date:  1977-11       Impact factor: 1.889

2.  Wound zygomycosis (mucormycosis) in otherwise healthy adults.

Authors:  B Vainrub; A Macareno; S Mandel; D M Musher
Journal:  Am J Med       Date:  1988-03       Impact factor: 4.965

3.  Hospital-acquired mucormycosis (Rhizopus rhizopodiformis) of skin and subcutaneous tissue: epidemiology, mycology and treatment.

Authors:  G Gartenberg; E J Bottone; G T Keusch; I Weitzman
Journal:  N Engl J Med       Date:  1978-11-16       Impact factor: 91.245

4.  Simple method of inducing sporulation by Apophysomyces elegans and Saksenaea vasiformis.

Authors:  A A Padhye; L Ajello
Journal:  J Clin Microbiol       Date:  1988-09       Impact factor: 5.948

5.  Rhinocerebral mucormycosis: premortem diagnosis and therapy.

Authors:  B R Meyers; G Wormser; S Z Hirschman; A Blitzer
Journal:  Arch Intern Med       Date:  1979-05

6.  Saksenaea vasiformis osteomyelitis.

Authors:  P F Pierce; M B Wood; G D Roberts; R H Fitzgerald; C Robertson; R S Edson
Journal:  J Clin Microbiol       Date:  1987-05       Impact factor: 5.948

7.  The changing spectrum of disease, etiology, and diagnosis of mucormycosis.

Authors:  A M Marchevsky; E J Bottone; S A Geller; D K Giger
Journal:  Hum Pathol       Date:  1980-09       Impact factor: 3.466

8.  Successful treatment of extensive posttraumatic soft-tissue and renal infections due to Apophysomyces elegans.

Authors:  P C Okhuysen; J H Rex; M Kapusta; C Fife
Journal:  Clin Infect Dis       Date:  1994-08       Impact factor: 9.079

Review 9.  Zygomycosis.

Authors:  M G Rinaldi
Journal:  Infect Dis Clin North Am       Date:  1989-03       Impact factor: 5.982

10.  Zygomycosis caused by Apophysomyces elegans.

Authors:  M A Wieden; K K Steinbronn; A A Padhye; L Ajello; F W Chandler
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

View more
  15 in total

1.  Femur osteomyelitis due to a mixed fungal infection in a previously healthy man.

Authors:  M Cimerman; N Gunde-Cimerman; P Zalar; T Perkovic
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

2.  Mucormycosis spondylodiscitis after lumbar disc puncture.

Authors:  Fei Chen; Guohua Lü; Yijun Kang; Zeming Ma; Chang Lu; Bin Wang; Jin Li; Jun Liu; Haisheng Li
Journal:  Eur Spine J       Date:  2005-11-18       Impact factor: 3.134

3.  Invasive Apophysomyces variabilis infection in a burn patient.

Authors:  Wilfred P dela Cruz; Tatjana P Calvano; Matthew E Griffith; Christopher E White; Seung H Kim; Deanna A Sutton; Elizabeth H Thompson; Jianmin Fu; Brian L Wickes; Josep Guarro; Duane R Hospenthal
Journal:  J Clin Microbiol       Date:  2012-05-23       Impact factor: 5.948

Review 4.  Mucormycosis caused by unusual mucormycetes, non-Rhizopus, -Mucor, and -Lichtheimia species.

Authors:  Marisa Z R Gomes; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

5.  Rhino-orbital-cerebral mucormycosis.

Authors:  Maria N Gamaletsou; Nikolaos V Sipsas; Emmanuel Roilides; Thomas J Walsh
Journal:  Curr Infect Dis Rep       Date:  2012-08       Impact factor: 3.725

6.  Apophysomyces elegans: epidemiology, amplified fragment length polymorphism typing, and in vitro antifungal susceptibility pattern.

Authors:  A Chakrabarti; M R Shivaprakash; I Curfs-Breuker; A Baghela; C H Klaassen; J F Meis
Journal:  J Clin Microbiol       Date:  2010-09-29       Impact factor: 5.948

7.  Efficacy of antifungal therapy in a nonneutropenic murine model of zygomycosis.

Authors:  Eric Dannaoui; Johan W Mouton; Jacques F G M Meis; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 8.  Bone and joint infections caused by mucormycetes: A challenging osteoarticular mycosis of the twenty-first century.

Authors:  Saad J Taj-Aldeen; Maria N Gamaletsou; Blandine Rammaert; Nikolaos V Sipsas; Valerie Zeller; Emmanuel Roilides; Dimitrios P Kontoyiannis; Michael Henry; Vidmantas Petraitis; Brad Moriyama; David W Denning; Olivier Lortholary; Thomas J Walsh
Journal:  Med Mycol       Date:  2017-10-01       Impact factor: 4.076

9.  Apophysomyces elegans: an emerging zygomycete in India.

Authors:  A Chakrabarti; A Ghosh; G S Prasad; J K David; S Gupta; A Das; V Sakhuja; N K Panda; S K Singh; S Das; T Chakrabarti
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

Review 10.  Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans.

Authors:  Kimberly P Liang; Imad M Tleyjeh; Walter R Wilson; Glenn D Roberts; Zelalem Temesgen
Journal:  J Clin Microbiol       Date:  2006-03       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.